BrainsWay Ltd - American Depositary Shares – Cashflow (NASDAQ:BWAY)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit 1.44 M884 K9.76 M1.28 M10.3 M — Mittelzufluss aus Investitionstätigkeit 2.46 M42.22 M42.17 M37.41 M30.31 M — Zahlungsströme aus der Finanzierungstätigkeit 1.03 M41.52 M1.55 M1.03 M18.26 M — Freier Cashflow 1.44 M884 K9.76 M1.28 M10.3 M —

BrainsWay Ltd - American Depositary Shares

BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.

BWAY

Financials

BrainsWay Ltd - American Depositary Shares

Nachrichten

Are Medical Stocks Lagging Alcon (ALC) This Year?

Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know

Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

New Strong Buy Stocks for April 13th

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

BrainsWay schließt Wandelanleihe über 6 Mio. US-Dollar für Neurolief ab

BrainsWay schließt Meilenstein-Investition von 1 Million US-Dollar in Partnerunternehmen aus Colorado ab

H.C. Wainwright halbiert Kursziel für Brainsway auf 15 USD nach ADS-Ratio-Änderung

Brainsway stock price target cut to $15 by H.C. Wainwright on ADS ratio change

BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call Transcript

Brainsway: EPS übertrifft Schätzungen um 0,02 $ - Umsatz besser als erwartet

Brainsway earnings beat by $0.02, revenue topped estimates